Portal de Periódicos da CAPES

The Role of Residual Host Immunity in Graft Failures following T‐cell‐depleted Marrow Transplants for Leukemiaa

1987; Wiley; Volume: 511; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1987.tb36274.x

1749-6632

Claudio Bordignon, Nancy A. Kernan, C Keever, E. Benazzi, Trudy N. Small, Joel A. Brochstein, Isabel Cunningham, N H Collins, David Emanuel, J Laver, H Castro-Malaspina, Neal Flomenberg, Sanjeev Gulati, James W. Burns, Brenda Shank, Bo Dupont, Richard O’Reilly,

Cytomegalovirus and herpesvirus research

Annals of the New York Academy of SciencesVolume 511, Issue 1 p. 442-446 The Role of Residual Host Immunity in Graft Failures following T-cell-depleted Marrow Transplants for Leukemiaa C. BORDIGNON, C. BORDIGNON Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorN. A. KERNAN, N. A. KERNAN Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorC. A. KEEVER, C. A. KEEVER Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorE. BENAZZI, E. BENAZZI Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorT. N. SMALL, T. N. SMALL Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorJ. BROCHSTEIN, J. BROCHSTEIN Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorI. CUNNINGHAM, I. CUNNINGHAM Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorN. H. COLLINS, N. H. COLLINS Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorD. EMANUEL, D. EMANUEL Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorJ. LAVER, J. LAVER Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorH. CASTRO-MALASPINA, H. CASTRO-MALASPINA Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorN. FLOMENBERG, N. FLOMENBERG Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorS. GULATI, S. GULATI Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorJ. BURNS, J. BURNS Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorB. SHANK, B. SHANK Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorB. DUPONT, B. DUPONT Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorR. J. O'REILLY, R. J. O'REILLY Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this author C. BORDIGNON, C. BORDIGNON Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorN. A. KERNAN, N. A. KERNAN Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorC. A. KEEVER, C. A. KEEVER Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorE. BENAZZI, E. BENAZZI Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorT. N. SMALL, T. N. SMALL Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorJ. BROCHSTEIN, J. BROCHSTEIN Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorI. CUNNINGHAM, I. CUNNINGHAM Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorN. H. COLLINS, N. H. COLLINS Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorD. EMANUEL, D. EMANUEL Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorJ. LAVER, J. LAVER Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorH. CASTRO-MALASPINA, H. CASTRO-MALASPINA Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorN. FLOMENBERG, N. FLOMENBERG Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorS. GULATI, S. GULATI Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorJ. BURNS, J. BURNS Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorB. SHANK, B. SHANK Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorB. DUPONT, B. DUPONT Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this authorR. J. O'REILLY, R. J. O'REILLY Bone Marrow Transplantation Service, Department of Human Immunogenetics and Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, New York 10021Search for more papers by this author First published: December 1987 https://doi.org/10.1111/j.1749-6632.1987.tb36274.xCitations: 8 a This work was supported by United States Public Health Service Grants CA23766, CA08748, and CA22507, as well as by the Zelda Weintraub Cancer Foundation, Robert J. Kleberg and Hellen C. Kleberg Foundation, Lila Acherson Dewitt-Wallace Foundation, Vincent Astor Foundation, Yankee-Frito Lay Challange Fund, Andrew Gaffney Foundation, Panwy Foundation, American Cancer Society, and XOMA Corporation. C. Bordignon is a Leukemia Society of America Special Fellow. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Thomas, E. D., R. Storb, R. A. Clift, A. Fefer, F. L. Johnson, P. E. Neiman, K. G. Lerner, H. Gluksberg & C. D. Buckner. 1975. Bone marrow transplantation. N. Engl. J. Med. 292: 832–843. 10.1056/NEJM197504172921605 CASPubMedWeb of Science®Google Scholar 2 O'Reilly, R. J. 1983. Allogeneic bone marrow transplantation: Current status and future directors. Blood 62: 941–964. PubMedWeb of Science®Google Scholar 3 Korngold, R. & J. Sprent. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148: 1687–1689. 10.1084/jem.148.6.1687 CASPubMedWeb of Science®Google Scholar 4 Prentice, H. G., G. Janossy, D. Skeggs, H. A. Blacklock, K. F. Bradstock, G. Goldstein & A. V. Hoffbrand. 1982. Use of anti-T cell monoclonal antibody OKT3 to prevent acute graft versus host disease in allogeneic bone marrow transplantation for acute leukemia. Lancet 1: 700–703. 10.1016/S0140-6736(82)92619-8 PubMedWeb of Science®Google Scholar 5 O'Reilly, R. J., N. Collins, J. Brochstein, N. Kernan, C. Keever, H. Castro-Malaspina, N. Flomenberg, J. Laver, S. Gulati, J. Burns, D. Emanuel, C. Bordignon, T. Small, D. Hornik, B. Kushner & B. Shank. 1986. Soybean lectin agglutination and E rosette depletion for removal of T cells from HLA identical marrow grafts: Results in 60 consecutive patients transplanted for hematopoietic malignancy. In Minimal Residual Disease in Acute Leukemia. A. Hagenbeck & B. Lowenberg, Eds. 337–433. Martinus Nijhoff. Dordrecht , The Netherlands . 10.1007/978-94-009-4273-8_31 Google Scholar 6 O'Reilly, R. J., N. H. Collins, N. A. Kernan, J. Brochstein, R. Dinsmore, D. Kirkpatrick, S. Siena, C. Keever, B. Jordan, B. Shank, L. Wolf, B. Dupont & Y. Reisner. 1985. Transplantation of marrow depleted of T cells by soybean lectin agglutination and E rosette depletion: Major histocompatibility complex-related graft resistance in leukemic transplant recipients. Transplant Proc. 17: 455–459. Web of Science®Google Scholar 7 Martin, P. J., J. A. Hansen, C. D. Buckner, J. E. Sanders, H. J. Deeg, P. Steward, F. R. Appelbaum, R. Clift, A. Fefer, R. P. Witherspoon, M. S. Kennedy, K. M. Sullivan, N. Flournoy, R. Storb & E. D. Thomas. 1985. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66: 664–672. 10.1182/blood.V66.3.664.664 CASPubMedWeb of Science®Google Scholar 8 Mitsuyasu, R. J., R. E. Champlin, R. P. Gale, G. Ho, C. Lenarsky, D. Winston, M. Selch, R. Elashoff, J. V. Giorgi, J. Wells, P. Terasaki, R. Billing & S. Feig. 1986. Treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for the prevention of Graft versus Host Disease. Ann. Int. Med. 105: 20–26. 10.7326/0003-4819-105-1-20 PubMedWeb of Science®Google Scholar 9 Kernan, N. A., N. Flomenberg, B. Dupont & R. J. O'Reilly. 1987. Graft rejection in recipients of T cell depleted HLA non-identical marrow transplants for leukemia: Identification of host derived anti-donor allocytotoxic T-lymphocytes. Transplantation 43: 842–847. 10.1097/00007890-198743060-00014 CASPubMedWeb of Science®Google Scholar 10 Keever, C. A., K. Welte, T. Small, J. Levick, M. Sullivan, M. Hauch, R. L. Evans & R. J. O'Reilly. 1987. Interleukin 2 activated killer cells in patients following transplants of soybean lectin separated and E-rosette depleted bone marrow. Blood. In press. PubMedGoogle Scholar 11 Kernan, N. A., N. Flomenberg, B. Dupont & R. J. O'Reilly. 1984. Identification of cytotoxic T lymphocytes in patients rejecting T cell depleted bone marrow transplants for leukemia. Blood 64 (5) Suppl. 1: 216a. Google Scholar 12 Bordignon, C., J. P. Daley & I. Nakamura. 1985. Hematopoietic histoincompatibility reactions by NK cells in vitro: Model for genetic resitance to marrow grafts. Science 230: 1398–1401. 10.1126/science.3906897 CASPubMedWeb of Science®Google Scholar Citing Literature Volume511, Issue1Normal and Neoplastic Blood Cells: From Genes to TherapyDecember 1987Pages 442-446 ReferencesRelatedInformation